美国 · SEC FORM 4
Cronos Group Inc.
CRON · Nasdaq · CIK 0001656472 · Healthcare · Drug Manufacturers—Specialty & Generic
内部人信号
当前没有活跃买入信号
0 qualifying P purchase groups
当前 180 天评分窗口
14 同一窗口内观察到的 Form 4 交易行
0 sales · 14 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2023-05-30 · ADLER JASON MARC · $65.2K
为什么没有活跃信号？
买入活动无
近期买入无
近期卖出无
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
Kenost Jared MatthewSee Remarks
○○○○
Wagner AdamSee remarks
○○
Doucet Terrence Gregory JosephSee Remarks
○○
Buggy ShannonSee Remarks
○○
Weigensberg AryeSee Remarks
○
● 买入▼ 卖出○ 其他
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2023-05-30 · ADLER JASON MARC.
近期 Form 4 活动
0买入
0卖出
55其他 Form 4 交易行
29SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他14 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 3,368,561
- 上期报告
- 3,253,266
- 日均成交量
- 896,120
- 回补天数
- 3.8
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2023-05-30 | ADLER JASON MARC | 买入 (P) | COMMON SHARES | 37,500 | USD 1.74 | USD 65,250 | SEC 申报 ↗ |
| 2023-05-25 | ADLER JASON MARC | 买入 (P) | COMMON SHARES | 100,000 | USD 1.80 | USD 180,000 | SEC 申报 ↗ |
| 2023-05-23 | ADLER JASON MARC | 买入 (P) | COMMON SHARES | 100,000 | USD 1.90 | USD 190,000 | SEC 申报 ↗ |
| 2023-05-19 | ADLER JASON MARC | 买入 (P) | COMMON SHARES | 100,000 | USD 1.89 | USD 189,000 | SEC 申报 ↗ |
| 2023-05-18 | ADLER JASON MARC | 买入 (P) | COMMON SHARES | 11,420 | USD 1.80 | USD 20,556 | SEC 申报 ↗ |
| 2023-05-17 | ADLER JASON MARC | 买入 (P) | COMMON SHARES | 59,300 | USD 1.71 | USD 101,403 | SEC 申报 ↗ |
| 2023-05-16 | ADLER JASON MARC | 买入 (P) | COMMON SHARES | 76,100 | USD 1.72 | USD 130,892 | SEC 申报 ↗ |
| 2023-05-15 | ADLER JASON MARC | 买入 (P) | COMMON SHARES | 19,000 | USD 1.76 | USD 33,440 | SEC 申报 ↗ |
| 2022-12-15 | ADLER JASON MARC | 买入 (P) | COMMON SHARES | 109,588 | USD 2.81 | USD 307,942 | SEC 申报 ↗ |
| 2022-12-14 | ADLER JASON MARC | 买入 (P) | COMMON SHARES | 94,600 | USD 2.83 | USD 267,718 | SEC 申报 ↗ |
| 2022-12-13 | ADLER JASON MARC | 买入 (P) | COMMON SHARES | 88,152 | USD 2.89 | USD 254,759 | SEC 申报 ↗ |
| 2022-12-12 | ADLER JASON MARC | 买入 (P) | COMMON SHARES | 86,000 | USD 2.90 | USD 249,400 | SEC 申报 ↗ |
| 2022-12-09 | ADLER JASON MARC | 买入 (P) | COMMON SHARES | 129,000 | USD 2.89 | USD 372,810 | SEC 申报 ↗ |
| 2022-12-08 | ADLER JASON MARC | 买入 (P) | COMMON SHARES | 162,400 | USD 2.86 | USD 464,464 | SEC 申报 ↗ |
| 2022-12-07 | ADLER JASON MARC | 买入 (P) | COMMON SHARES | 119,000 | USD 2.93 | USD 348,670 | SEC 申报 ↗ |
Form 4 申报证据
55 transaction lines in the latest 365-day window; 348 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-05-12 | Wagner Adam | 期权行权／转换 (M) | COMMON SHARES | 10,367 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-12 | Kenost Jared Matthew | 期权行权／转换 (M) | COMMON SHARES | 9,412 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-12 | Kenost Jared Matthew | 代扣税 (F) | COMMON SHARES | 3,701 | USD 2.75 | USD 10,178 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-05-12 | Wagner Adam | 期权行权／转换 (M) | COMMON SHARES | 10,367 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-12 | Kenost Jared Matthew | 期权行权／转换 (M) | COMMON SHARES | 9,412 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-12 | Kenost Jared Matthew | 代扣税 (F) | COMMON SHARES | 3,701 | USD 2.75 | USD 10,178 | SEC 申报 ↗ |
| 2026-05-12 | Doucet Terrence Gregory Joseph | 期权行权／转换 (M) | COMMON SHARES | 10,597 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-12 | Doucet Terrence Gregory Joseph | 代扣税 (F) | COMMON SHARES | 5,199 | USD 3.75 | USD 19,496 | SEC 申报 ↗ |
| 2026-05-12 | Buggy Shannon | 期权行权／转换 (M) | COMMON SHARES | 20,622 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-12 | Buggy Shannon | 代扣税 (F) | COMMON SHARES | 9,179 | USD 2.75 | USD 25,242 | SEC 申报 ↗ |
| 2026-05-10 | Weigensberg Arye | 期权行权／转换 (M) | COMMON SHARES | 3,118 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-10 | Wagner Adam | 期权行权／转换 (M) | COMMON SHARES | 20,470 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-10 | Kenost Jared Matthew | 期权行权／转换 (M) | COMMON SHARES | 12,649 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-10 | Kenost Jared Matthew | 代扣税 (F) | COMMON SHARES | 4,774 | USD 2.54 | USD 12,126 | SEC 申报 ↗ |
| 2026-03-19 | Shlimak Anna | 期权行权／转换 (M) | COMMON SHARES | 28,429 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-19 | Shlimak Anna | 代扣税 (F) | COMMON SHARES | 9,767 | USD 2.54 | USD 24,808 | SEC 申报 ↗ |
| 2026-03-15 | Weigensberg Arye | 期权行权／转换 (M) | COMMON SHARES | 24,236 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-15 | Shlimak Anna | 期权行权／转换 (M) | COMMON SHARES | 45,226 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-15 | Shlimak Anna | 代扣税 (F) | COMMON SHARES | 16,354 | USD 2.50 | USD 40,885 | SEC 申报 ↗ |
| 2026-03-15 | JACOBSON JEFFREY DAVID | 期权行权／转换 (M) | COMMON SHARES | 59,191 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-15 | JACOBSON JEFFREY DAVID | 代扣税 (F) | COMMON SHARES | 22,552 | USD 2.50 | USD 56,380 | SEC 申报 ↗ |
| 2026-03-15 | GORENSTEIN MICHAEL RYAN | 期权行权／转换 (M) | COMMON SHARES | 324,540 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-15 | GORENSTEIN MICHAEL RYAN | 代扣税 (F) | COMMON SHARES | 127,706 | USD 2.50 | USD 319,265 | SEC 申报 ↗ |
| 2026-03-15 | Doucet Terrence Gregory Joseph | 期权行权／转换 (M) | COMMON SHARES | 23,897 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-15 | Doucet Terrence Gregory Joseph | 代扣税 (F) | COMMON SHARES | 12,276 | USD 3.44 | USD 42,229 | SEC 申报 ↗ |
| 2026-03-15 | Buggy Shannon | 期权行权／转换 (M) | COMMON SHARES | 20,938 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-15 | Buggy Shannon | 代扣税 (F) | COMMON SHARES | 9,202 | USD 2.50 | USD 23,005 | SEC 申报 ↗ |
| 2026-03-12 | Weigensberg Arye | 期权行权／转换 (M) | COMMON SHARES | 26,825 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-12 | Wagner Adam | 期权行权／转换 (M) | COMMON SHARES | 15,715 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-12 | Shlimak Anna | 期权行权／转换 (M) | COMMON SHARES | 47,368 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-12 | Shlimak Anna | 代扣税 (F) | COMMON SHARES | 17,230 | USD 2.56 | USD 44,109 | SEC 申报 ↗ |
| 2026-03-12 | JACOBSON JEFFREY DAVID | 期权行权／转换 (M) | COMMON SHARES | 65,179 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-12 | JACOBSON JEFFREY DAVID | 代扣税 (F) | COMMON SHARES | 24,926 | USD 2.56 | USD 63,811 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | CRON |
| CIK | 0001656472 |
| 行业 | Healthcare |
| 细分行业 | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2833 Medicinal Chemicals & Botanical Products |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 348 transaction lines from 2020-08-07 to 2026-05-12 51 P purchase lines · 16 S sale lines · 281 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.